Bughaw, Marnidette B.

HRN: 08-80-94  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2022
CEFUROXIME 500MG (TAB)
05/27/2022
06/03/2022
ORAL
500mg
Q12
Prophylaxis For Soft Tissue Injury Sec To MVA
Waiting Final Action 

Indication:      Type of Infection:      Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: